MassNAELA Honors Elder Law Month by Advocating State Legislation Granting Financial Assistance for In-Home Care

BOSTON–(BUSINESS WIRE)–#ElderLaw–The Massachusetts Chapter of the National Academy of Elder Law Attorneys (MassNAELA) celebrates May as Elder Law Month by working to empower residents of the Commonwealth to receive care in their home as they age. Many Massachusetts residents are forced to leave their home to receive care, because they do not have the resources … [Read more…]

SpotSee Rolls Out New Tilt Monitor, TiltWatch RFID

The RFID-enabled, tilt-monitoring product helps deter damage throughout the supply chain DALLAS–(BUSINESS WIRE)–SpotSee®, a global leader in supply chain indicators that protect products against damage and ensure supply chain integrity, has expanded its TiltWatch product line to include an indicator that combines tilt-monitoring capabilities with passive radio-frequency identification (RFID) technology. The new TiltWatch® RFID alerts … [Read more…]

Eighty-Six Percent of Financial Services Business Leaders Lack Confidence in Data, Research Reveals

More than a third operating on assumptions rather than on real-time information CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nearly nine of ten – a whopping 86% — of business leaders at financial services companies aren’t confident that their data can be used for decision-making, according to research commissioned by InterSystems. The study of more than 550 business leaders across … [Read more…]

Welldoc Earns 2022 Great Place to Work Certification™

COLUMBIA, Md.–(BUSINESS WIRE)–Welldoc®, a digital health leader revolutionizing chronic care, today announced that it was Certified™ by Great Place to Work®. The prestigious award is based entirely on feedback from current employees regarding their experience working at Welldoc. This year, 95 percent of employees said Welldoc is a great place to work – 36 points … [Read more…]

Tech Tackles Cancer Announces WBOS Rock 92.9 as Media Partner for June 21 Event in Cambridge, Mass.

 Veteran Boston Air Personality Adam 12 to Emcee Fundraiser Supporting Pediatric Cancer Treatments BOSTON–(BUSINESS WIRE)–#AI–Hack/Reduce, a non-profit focused on creating talent and technologies for Boston’s big data-driven economy, today announced that Beasley Media Group’s WBOS (ROCK 92.9) is an official media partner of Tech Tackles Cancer’s (TTC) charity event being held on June 21, 2022, … [Read more…]

Infinity Pharmaceuticals to Participate in Upcoming H.C. Wainwright Global Investment Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, today announced that management will be presenting a corporate overview and participating in 1-on-1 meetings at the upcoming H.C. Wainwright Global Investment Conference May 23-25, 2022. H.C. Wainwright Global Investment Conference Presentation (hybrid) Date: Tuesday, … [Read more…]

NanoVibronix Reports First Quarter 2022 Financial Results

Expanded Distribution, Entry into New Geographic Markets and Regulatory Approvals Advancing Efforts Towards Full Commercialization ELMSFORD, N.Y.–(BUSINESS WIRE)–NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today reported its financial results for the quarter ended March 31, 2022. First Quarter 2022 Financial and … [Read more…]

Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating Daxdilimab (HZN-7734) for the Treatment of Alopecia Areata

DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced the first patient has enrolled in a Phase 2, open-label, proof-of-concept trial to evaluate its development-stage medicine daxdilimab (HZN-7734), a potentially first-in-class, fully human monoclonal antibody targeting immunoglobulin-like transcript 7 (ILT7), to treat people with moderate-to-severe alopecia areata. Alopecia areata is a common, acute onset autoimmune disorder … [Read more…]

MEI Pharma to Present at the H.C. Wainwright Global Investment Conference 2022

SAN DIEGO–(BUSINESS WIRE)–MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced its participation in the H.C. Wainwright Global Investment Conference 2022. The company will present a company overview and business update available for on-demand listening starting Tuesday, May 24, 2022, 7:00 a.m. Eastern Time that will … [Read more…]